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Letters to the EditorInsulin resistance predicts rapid virological response in non-diabetic,
non-cirrhotic genotype 1 HCV patients treated with peginterferon
alpha-2b plus ribavirin: Some issuesTo the Editor:
We read with great interest the report by Grasso et al. in a recent
issue of the Journal of Hepatology [1]. They enrolled 90 consecu-
tive, non-diabetic, non-cirrhotic patients with genotype 1 chronic
hepatitis C, treated with peginterferon alpha-2b plus ribavirin.
Two issues need clariﬁcation.
The ﬁrst concerns the unit of sensitivity of the qualitative
reverse-transcription PCR test, Roche Cobas Amplicor assay
which was mistakenly written as copies per millilitre in this
paper. It should be international units per millilitre [2].
Secondly, rapid virological response (RVR) [3,4] and homeo-
stasis model assessment of insulin resistance (HOMA-IR) [5,6]
have been important factors associated with achievement of a
sustained virological response (SVR). However, the current study
observed that HOMA-IR could predict rapid virological response
(RVR) but not SVR [1]. There is low probability of normal distri-
bution for HOMA-IR. For example, the mean value and standard
deviation of HOMA-IR was 2.6 and 2.1, respectively, in the cur-
rent study. Therefore, non-parametric inferential statistical
methods or logarithmic transformation of original values to
improve skewness before analyses are preferred in this situation.
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To the Editor:
We read with interest the comment by Wu and colleagues on our
recently published paper [1]. Two issues indeed need to be clariﬁed.
The unit of sensitivity of the qualitative reverse-transcription
PCR test, Roche Cobas Amplicor assay, was mistakenly reported
inthePatientsandmethodssectionascopiespermillilitre, ratherthan
as international units per millilitre. We apologize for this oversight.
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Levene test was applied to HOMA-IR, a Kolmogorov–Smirnov
test conﬁrmed a non-normal distribution of HOMA-IR values,
as suggested by Wu and colleagues. The Mann–Whitney test,
which had actually been applied in our former analysis, failed
to demonstrate a signiﬁcant difference in HOMA-IR between
patients with and without SVR, although the p-value was
slightly better than the one reported in Table 1. Nevertheless,
we agree that this clariﬁcation should have been included in
the statistical analysis section.
